Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:27 PM
Ignite Modification Date:
2025-12-24 @ 4:27 PM
NCT ID:
NCT01284166
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of ocular hypertension or glaucoma in each eye
* Requires IOP-lowering treatment in both eyes
Exclusion Criteria:
* Use of dorzolamide or carbonic anhydrase within 4 weeks
* Any other active ocular disease other than ocular hypertension or glaucoma (eg, uveitis, ocular infections or severe dry eye)
* Required chronic use of ocular medications other than study medication during the study (intermittent use of certain products eg, artificial tears are permitted)
* Use of oral, injectable or topical ophthalmic steroids within 21 days
* Any eye laser surgery within 3 months
* Any intraocular surgery (eg cataract surgery) within 6 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01284166
Study Brief:
Protocol Section:
NCT01284166